|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6776792B1
(en)
|
1997-04-24 |
2004-08-17 |
Advanced Cardiovascular Systems Inc. |
Coated endovascular stent
|
|
DK1019111T3
(da)
|
1998-04-27 |
2002-10-14 |
Surmodics Inc |
Overtræk der frigiver bioaktivt stof
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
PL351949A1
(en)
|
1999-04-26 |
2003-07-14 |
Gmp Vision Solutions |
Stent and method of treating glaucoma
|
|
US6790228B2
(en)
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
US20070032853A1
(en)
|
2002-03-27 |
2007-02-08 |
Hossainy Syed F |
40-O-(2-hydroxy)ethyl-rapamycin coated stent
|
|
US7682647B2
(en)
|
1999-09-03 |
2010-03-23 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of a drug eluting implantable medical device
|
|
US7807211B2
(en)
|
1999-09-03 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of an implantable medical device
|
|
US6908624B2
(en)
*
|
1999-12-23 |
2005-06-21 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US7682648B1
(en)
|
2000-05-31 |
2010-03-23 |
Advanced Cardiovascular Systems, Inc. |
Methods for forming polymeric coatings on stents
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
US6451373B1
(en)
|
2000-08-04 |
2002-09-17 |
Advanced Cardiovascular Systems, Inc. |
Method of forming a therapeutic coating onto a surface of an implantable prosthesis
|
|
PT1313415E
(pt)
|
2000-08-30 |
2008-11-25 |
Univ Johns Hopkins |
Dispositivos para entrega intra-ocular de fármacos
|
|
US6953560B1
(en)
|
2000-09-28 |
2005-10-11 |
Advanced Cardiovascular Systems, Inc. |
Barriers for polymer-coated implantable medical devices and methods for making the same
|
|
US6783793B1
(en)
|
2000-10-26 |
2004-08-31 |
Advanced Cardiovascular Systems, Inc. |
Selective coating of medical devices
|
|
US7807210B1
(en)
|
2000-10-31 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Hemocompatible polymers on hydrophobic porous polymers
|
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
|
US6824559B2
(en)
|
2000-12-22 |
2004-11-30 |
Advanced Cardiovascular Systems, Inc. |
Ethylene-carboxyl copolymers as drug delivery matrices
|
|
US6663662B2
(en)
|
2000-12-28 |
2003-12-16 |
Advanced Cardiovascular Systems, Inc. |
Diffusion barrier layer for implantable devices
|
|
CA2433528A1
(fr)
*
|
2001-01-26 |
2002-08-01 |
Bausch & Lomb Incorporated |
Procede ameliore de fabrication de dispositifs d'administration de medicaments a liberation modifiee
|
|
US6780424B2
(en)
|
2001-03-30 |
2004-08-24 |
Charles David Claude |
Controlled morphologies in polymer drug for release of drugs from polymer films
|
|
US20020148138A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Egan Brian A. |
Smart tread boot covers
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US7488303B1
(en)
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
CA2683224C
(fr)
|
2001-04-07 |
2014-12-02 |
Glaukos Corporation |
Systeme et methodes connexes de traitement des affections oculaires
|
|
US6712845B2
(en)
|
2001-04-24 |
2004-03-30 |
Advanced Cardiovascular Systems, Inc. |
Coating for a stent and a method of forming the same
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
AU2002305400A1
(en)
|
2001-05-03 |
2002-11-18 |
Glaukos Corporation |
Medical device and methods of use for glaucoma treatment
|
|
EP1387671A1
(fr)
|
2001-05-03 |
2004-02-11 |
MASSACHUSETTS EYE & EAR INFIRMARY |
Dispositif d'administration de medicament implantable et utilisation associee
|
|
US6656506B1
(en)
|
2001-05-09 |
2003-12-02 |
Advanced Cardiovascular Systems, Inc. |
Microparticle coated medical device
|
|
US6743462B1
(en)
|
2001-05-31 |
2004-06-01 |
Advanced Cardiovascular Systems, Inc. |
Apparatus and method for coating implantable devices
|
|
US7883717B2
(en)
|
2001-06-12 |
2011-02-08 |
Johns Hopkins University |
Reservoir device for intraocular drug delivery
|
|
US6695920B1
(en)
|
2001-06-27 |
2004-02-24 |
Advanced Cardiovascular Systems, Inc. |
Mandrel for supporting a stent and a method of using the mandrel to coat a stent
|
|
US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
|
US6565659B1
(en)
|
2001-06-28 |
2003-05-20 |
Advanced Cardiovascular Systems, Inc. |
Stent mounting assembly and a method of using the same to coat a stent
|
|
US7682669B1
(en)
|
2001-07-30 |
2010-03-23 |
Advanced Cardiovascular Systems, Inc. |
Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
US8303651B1
(en)
|
2001-09-07 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
|
|
JP2005502426A
(ja)
|
2001-09-14 |
2005-01-27 |
フランシス ジェイ マーティン |
治療剤の徐放のための微細加工ナノ細孔デバイス
|
|
US7989018B2
(en)
|
2001-09-17 |
2011-08-02 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
|
US7285304B1
(en)
|
2003-06-25 |
2007-10-23 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
|
US6753071B1
(en)
|
2001-09-27 |
2004-06-22 |
Advanced Cardiovascular Systems, Inc. |
Rate-reducing membrane for release of an agent
|
|
US7223282B1
(en)
|
2001-09-27 |
2007-05-29 |
Advanced Cardiovascular Systems, Inc. |
Remote activation of an implantable device
|
|
US6709514B1
(en)
|
2001-12-28 |
2004-03-23 |
Advanced Cardiovascular Systems, Inc. |
Rotary coating apparatus for coating implantable medical devices
|
|
US20030180294A1
(en)
*
|
2002-02-22 |
2003-09-25 |
Devries Gerald W. |
Methods of extending corneal graft survival
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
CA2478772C
(fr)
|
2002-03-11 |
2011-01-18 |
Alcon, Inc. |
Systeme de distribution de medicament implantable
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US7919075B1
(en)
|
2002-03-20 |
2011-04-05 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
US8202845B2
(en)
*
|
2002-04-18 |
2012-06-19 |
Acuity Pharmaceuticals, Inc. |
Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
US7442711B2
(en)
|
2002-05-17 |
2008-10-28 |
Othera Holding, Inc. |
Amelioration of the development of cataracts and other ophthalmic diseases
|
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
|
US7217426B1
(en)
|
2002-06-21 |
2007-05-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings containing polycationic peptides for cardiovascular therapy
|
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
US8506617B1
(en)
|
2002-06-21 |
2013-08-13 |
Advanced Cardiovascular Systems, Inc. |
Micronized peptide coated stent
|
|
US7011842B1
(en)
|
2002-06-21 |
2006-03-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
US6994867B1
(en)
|
2002-06-21 |
2006-02-07 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing L-arginine
|
|
US7070798B1
(en)
|
2002-06-21 |
2006-07-04 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
|
|
US7033602B1
(en)
|
2002-06-21 |
2006-04-25 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of coating implantable medical devices
|
|
US7056523B1
(en)
|
2002-06-21 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
US6930127B2
(en)
*
|
2002-08-15 |
2005-08-16 |
Eaton Veterinary Laboratories, Inc. |
Veterinary treatment of ophthalmic disease in animals using topical tacrolimus
|
|
US7087263B2
(en)
|
2002-10-09 |
2006-08-08 |
Advanced Cardiovascular Systems, Inc. |
Rare limiting barriers for implantable medical devices
|
|
WO2004036182A2
(fr)
*
|
2002-10-17 |
2004-04-29 |
Control Delivery Systems, Inc. |
Procede de suivi de traitement de maladie
|
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7022372B1
(en)
|
2002-11-12 |
2006-04-04 |
Advanced Cardiovascular Systems, Inc. |
Compositions for coating implantable medical devices
|
|
US6896965B1
(en)
|
2002-11-12 |
2005-05-24 |
Advanced Cardiovascular Systems, Inc. |
Rate limiting barriers for implantable devices
|
|
US20050013845A1
(en)
*
|
2002-11-12 |
2005-01-20 |
Warren Stephen L. |
Adhesive bioerodible ocular drug delivery system
|
|
US6982004B1
(en)
|
2002-11-26 |
2006-01-03 |
Advanced Cardiovascular Systems, Inc. |
Electrostatic loading of drugs on implantable medical devices
|
|
US7776926B1
(en)
|
2002-12-11 |
2010-08-17 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible coating for implantable medical devices
|
|
US7758880B2
(en)
|
2002-12-11 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible polyacrylate compositions for medical applications
|
|
US7074276B1
(en)
|
2002-12-12 |
2006-07-11 |
Advanced Cardiovascular Systems, Inc. |
Clamp mandrel fixture and a method of using the same to minimize coating defects
|
|
US8435550B2
(en)
|
2002-12-16 |
2013-05-07 |
Abbot Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
US20060002968A1
(en)
|
2004-06-30 |
2006-01-05 |
Gordon Stewart |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
|
|
US7094256B1
(en)
|
2002-12-16 |
2006-08-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical device containing polycationic peptides
|
|
US7758881B2
(en)
|
2004-06-30 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
NZ540885A
(en)
*
|
2002-12-20 |
2009-02-28 |
Chakshu Res Inc |
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
|
US8185209B2
(en)
*
|
2003-01-03 |
2012-05-22 |
Board Of Trustees Operating Michigan State University |
Methods to extend vision to infrared wavelengths
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
MXPA05007651A
(es)
|
2003-01-16 |
2005-10-26 |
Univ Pennsylvania |
Composiciones y metodos para la inhibicion por arnsi de la molecula de adhesion intercelular-1.
|
|
US6926919B1
(en)
|
2003-02-26 |
2005-08-09 |
Advanced Cardiovascular Systems, Inc. |
Method for fabricating a coating for a medical device
|
|
US7063884B2
(en)
|
2003-02-26 |
2006-06-20 |
Advanced Cardiovascular Systems, Inc. |
Stent coating
|
|
US7563483B2
(en)
|
2003-02-26 |
2009-07-21 |
Advanced Cardiovascular Systems Inc. |
Methods for fabricating a coating for implantable medical devices
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7572298B2
(en)
*
|
2003-03-28 |
2009-08-11 |
Ethicon, Inc. |
Implantable medical devices and methods for making same
|
|
US7012106B2
(en)
*
|
2003-03-28 |
2006-03-14 |
Ethicon, Inc. |
Reinforced implantable medical devices
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
AU2004237774B2
(en)
*
|
2003-05-02 |
2009-09-10 |
Surmodics, Inc. |
Implantable controlled release bioactive agent delivery device
|
|
US20040225250A1
(en)
|
2003-05-05 |
2004-11-11 |
Michael Yablonski |
Internal shunt and method for treating glaucoma
|
|
US7279174B2
(en)
|
2003-05-08 |
2007-10-09 |
Advanced Cardiovascular Systems, Inc. |
Stent coatings comprising hydrophilic additives
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US20050118344A1
(en)
|
2003-12-01 |
2005-06-02 |
Pacetti Stephen D. |
Temperature controlled crimping
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
JP4948166B2
(ja)
|
2003-06-27 |
2012-06-06 |
エチコン、インコーポレイテッド |
分娩後由来細胞を用いた軟骨と骨の修復と再生
|
|
US7875272B2
(en)
*
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US8790637B2
(en)
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
US8491883B2
(en)
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7056591B1
(en)
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
|
US7785512B1
(en)
|
2003-07-31 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
|
|
US7431959B1
(en)
|
2003-07-31 |
2008-10-07 |
Advanced Cardiovascular Systems Inc. |
Method and system for irradiation of a drug eluting implantable medical device
|
|
US7645474B1
(en)
|
2003-07-31 |
2010-01-12 |
Advanced Cardiovascular Systems, Inc. |
Method and system of purifying polymers for use with implantable medical devices
|
|
WO2005027906A1
(fr)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Administration transsclerale d'agents therapeutiques
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7955616B2
(en)
*
|
2003-09-23 |
2011-06-07 |
Orthocon, Inc. |
Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
|
|
CA2539635A1
(fr)
|
2003-09-23 |
2005-04-21 |
Orthotherapeutics, Llc. |
Implants hemostatiques bioabsorbables de type mastic
|
|
CA2824210A1
(fr)
*
|
2003-09-23 |
2005-04-21 |
Orthocon, Inc. |
Implants absorbables et leurs procedes d'utilisation pour une hemostase et pour traiter des defauts osseux
|
|
US7441513B1
(en)
|
2003-09-26 |
2008-10-28 |
Advanced Cardiovascular Systems, Inc. |
Plasma-generated coating apparatus for medical devices and a method of coating deposition
|
|
US8016865B2
(en)
|
2003-09-29 |
2011-09-13 |
Depuy Mitek, Inc. |
Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
|
|
US7198675B2
(en)
|
2003-09-30 |
2007-04-03 |
Advanced Cardiovascular Systems |
Stent mandrel fixture and method for selectively coating surfaces of a stent
|
|
US7318932B2
(en)
|
2003-09-30 |
2008-01-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices comprising hydrolitically stable adducts of poly(ethylene-co-vinyl alcohol) and methods for fabricating the same
|
|
US7704544B2
(en)
|
2003-10-07 |
2010-04-27 |
Advanced Cardiovascular Systems, Inc. |
System and method for coating a tubular implantable medical device
|
|
US7329413B1
(en)
|
2003-11-06 |
2008-02-12 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US7291125B2
(en)
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
|
AU2004293105B2
(en)
*
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US8192752B2
(en)
|
2003-11-21 |
2012-06-05 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
|
|
US7560492B1
(en)
|
2003-11-25 |
2009-07-14 |
Advanced Cardiovascular Systems, Inc. |
Polysulfone block copolymers as drug-eluting coating material
|
|
US7807722B2
(en)
|
2003-11-26 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial coating compositions and methods of making and using thereof
|
|
JP5009623B2
(ja)
*
|
2003-12-05 |
2012-08-22 |
イノレーン リミティド ライアビリティ カンパニー |
改良された眼内レンズ
|
|
WO2005055873A2
(fr)
*
|
2003-12-05 |
2005-06-23 |
Innfocus, Llc |
Dispositif ameliore a implant de traitement du glaucome
|
|
US7220816B2
(en)
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
|
US7435788B2
(en)
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US8309112B2
(en)
|
2003-12-24 |
2012-11-13 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
|
|
US7563324B1
(en)
|
2003-12-29 |
2009-07-21 |
Advanced Cardiovascular Systems Inc. |
System and method for coating an implantable medical device
|
|
US7976520B2
(en)
*
|
2004-01-12 |
2011-07-12 |
Nulens Ltd. |
Eye wall anchored fixtures
|
|
WO2005070333A1
(fr)
*
|
2004-01-13 |
2005-08-04 |
Orthobiologica, Inc. |
Administration d'un medicament a une articulation
|
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
|
SG188122A1
(en)
|
2004-01-23 |
2013-03-28 |
Advanced Cell Tech Inc |
Improved modalities for the treatment of degenerative diseases of the retina
|
|
US7794704B2
(en)
|
2004-01-23 |
2010-09-14 |
Advanced Cell Technology, Inc. |
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
|
|
US8685431B2
(en)
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
|
US8551512B2
(en)
|
2004-03-22 |
2013-10-08 |
Advanced Cardiovascular Systems, Inc. |
Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
|
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
|
JP2007532197A
(ja)
|
2004-04-06 |
2007-11-15 |
サーモディクス，インコーポレイティド |
生物活性物質のための被覆組成物
|
|
US20050232972A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
US20050277139A1
(en)
*
|
2004-04-26 |
2005-12-15 |
Itzhak Bentwich |
Methods and apparatus for the detection and validation of microRNAs
|
|
US7553377B1
(en)
|
2004-04-27 |
2009-06-30 |
Advanced Cardiovascular Systems, Inc. |
Apparatus and method for electrostatic coating of an abluminal stent surface
|
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US7820732B2
(en)
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
|
WO2005110374A1
(fr)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Systemes de distribution de medicaments intraoculaires contenant un agent therapeutique, une cyclodextrine et un composant polymere
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
AU2005240078A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US8591885B2
(en)
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
WO2005107708A1
(fr)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Implants d'inhibiteurs de tyrosine kinase intravitreens, biodegradables
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US8455656B2
(en)
*
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8293890B2
(en)
|
2004-04-30 |
2012-10-23 |
Advanced Cardiovascular Systems, Inc. |
Hyaluronic acid based copolymers
|
|
BRPI0511462A
(pt)
*
|
2004-05-25 |
2007-12-26 |
Othera Pharmaceuticals Inc |
medicamentos e pró-medicamentos óculo-seletivos
|
|
US9561309B2
(en)
|
2004-05-27 |
2017-02-07 |
Advanced Cardiovascular Systems, Inc. |
Antifouling heparin coatings
|
|
US7563780B1
(en)
|
2004-06-18 |
2009-07-21 |
Advanced Cardiovascular Systems, Inc. |
Heparin prodrugs and drug delivery stents formed therefrom
|
|
EP2803357B1
(fr)
|
2004-06-25 |
2020-11-18 |
The Johns-Hopkins University |
Inhibiteurs d'angiogenèse
|
|
US20050287184A1
(en)
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
|
EP2377569A1
(fr)
|
2004-07-02 |
2011-10-19 |
QLT Plug Delivery, Inc. |
Dispositif de mise en place d'un moyen de traitement et méthodes destinées a la mise en place dans l'oeil de ce type de moyen de traitement a l'aide dudit dispositif de mise en place
|
|
WO2006014484A2
(fr)
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Procedes et dispositifs pour le traitement d'affections oculaires
|
|
BRPI0513243B8
(pt)
*
|
2004-07-12 |
2021-05-25 |
Allergan Inc |
composições oftálmicas e respectivos usos
|
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
|
US7494665B1
(en)
|
2004-07-30 |
2009-02-24 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing siloxane monomers
|
|
US8357391B2
(en)
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
|
US7311980B1
(en)
|
2004-08-02 |
2007-12-25 |
Advanced Cardiovascular Systems, Inc. |
Polyactive/polylactic acid coatings for an implantable device
|
|
US8541028B2
(en)
|
2004-08-04 |
2013-09-24 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
|
US7648727B2
(en)
|
2004-08-26 |
2010-01-19 |
Advanced Cardiovascular Systems, Inc. |
Methods for manufacturing a coated stent-balloon assembly
|
|
US7244443B2
(en)
|
2004-08-31 |
2007-07-17 |
Advanced Cardiovascular Systems, Inc. |
Polymers of fluorinated monomers and hydrophilic monomers
|
|
US8603528B2
(en)
*
|
2004-09-16 |
2013-12-10 |
Abyrx, Inc. |
Compositions and method for the reduction of post-operative pain
|
|
US8110211B2
(en)
|
2004-09-22 |
2012-02-07 |
Advanced Cardiovascular Systems, Inc. |
Medicated coatings for implantable medical devices including polyacrylates
|
|
US20060067979A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
MX344532B
(es)
|
2004-10-01 |
2016-12-19 |
Ramscor Inc |
Composiciones de farmaco de liberacion sostenida convenientemente implantables.
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US7166680B2
(en)
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
|
US8043609B2
(en)
|
2004-10-08 |
2011-10-25 |
Potentia Pharmaceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
WO2006042252A2
(fr)
*
|
2004-10-08 |
2006-04-20 |
Potentia Pharmeceuticals, Inc. |
Proteines regulatrices du complement viral pour troubles de la vue
|
|
US8246949B2
(en)
*
|
2004-10-27 |
2012-08-21 |
Aciont, Inc. |
Methods and devices for sustained in-vivo release of an active agent
|
|
US8603634B2
(en)
|
2004-10-27 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
End-capped poly(ester amide) copolymers
|
|
US7481835B1
(en)
|
2004-10-29 |
2009-01-27 |
Advanced Cardiovascular Systems, Inc. |
Encapsulated covered stent
|
|
US7390497B2
(en)
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
|
US7547447B2
(en)
*
|
2004-11-15 |
2009-06-16 |
Doheny Eye Institute |
Bioartificial lacrimal gland
|
|
EP1824496A4
(fr)
*
|
2004-11-17 |
2008-07-16 |
Joanne Mclaurin |
Préparations comprenant des dérivés de scyllo-inositol et méthodes de traitement de troubles d agrégation protéinique
|
|
US7214759B2
(en)
*
|
2004-11-24 |
2007-05-08 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same
|
|
JP2008521489A
(ja)
*
|
2004-11-24 |
2008-06-26 |
テラカイン コーポレイション |
眼球内薬物送達のための移植物
|
|
US7588642B1
(en)
|
2004-11-29 |
2009-09-15 |
Advanced Cardiovascular Systems, Inc. |
Abluminal stent coating apparatus and method using a brush assembly
|
|
US8609123B2
(en)
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
|
US7892592B1
(en)
|
2004-11-30 |
2011-02-22 |
Advanced Cardiovascular Systems, Inc. |
Coating abluminal surfaces of stents and other implantable medical devices
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
US7632307B2
(en)
|
2004-12-16 |
2009-12-15 |
Advanced Cardiovascular Systems, Inc. |
Abluminal, multilayer coating constructs for drug-delivery stents
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US7604818B2
(en)
|
2004-12-22 |
2009-10-20 |
Advanced Cardiovascular Systems, Inc. |
Polymers of fluorinated monomers and hydrocarbon monomers
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
EP1831356B1
(fr)
*
|
2004-12-23 |
2017-01-25 |
DePuy Synthes Products, Inc. |
Cellules postnatales derivees de tissus du cordon ombilical, et procedes de production et d'utilisation de celles-ci
|
|
PT1835924E
(pt)
|
2004-12-23 |
2013-11-19 |
Ethicon Inc |
Tratamento da doença de parkinson e desordens relacionadas usando células derivadas do pós-parto
|
|
US7419504B2
(en)
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
|
US8007775B2
(en)
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
|
US7202325B2
(en)
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
US20060182771A1
(en)
|
2005-02-09 |
2006-08-17 |
Dor Philippe J |
Formulations for ocular treatment
|
|
WO2006091459A2
(fr)
|
2005-02-24 |
2006-08-31 |
Joslin Diabetes Center, Inc. |
Compositions et methodes permettant de traiter la permeabilite vasculaire
|
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
US20070077270A1
(en)
*
|
2005-03-28 |
2007-04-05 |
Clemson University |
Delivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear
|
|
US7795467B1
(en)
|
2005-04-26 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Bioabsorbable, biobeneficial polyurethanes for use in medical devices
|
|
US8778375B2
(en)
|
2005-04-29 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Amorphous poly(D,L-lactide) coating
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US7637941B1
(en)
|
2005-05-11 |
2009-12-29 |
Advanced Cardiovascular Systems, Inc. |
Endothelial cell binding coatings for rapid encapsulation of bioerodable stents
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US7622070B2
(en)
|
2005-06-20 |
2009-11-24 |
Advanced Cardiovascular Systems, Inc. |
Method of manufacturing an implantable polymeric medical device
|
|
US7823533B2
(en)
|
2005-06-30 |
2010-11-02 |
Advanced Cardiovascular Systems, Inc. |
Stent fixture and method for reducing coating defects
|
|
US8021676B2
(en)
|
2005-07-08 |
2011-09-20 |
Advanced Cardiovascular Systems, Inc. |
Functionalized chemically inert polymers for coatings
|
|
US7749530B2
(en)
|
2005-07-13 |
2010-07-06 |
Allergan, Inc. |
Kinase inhibitors
|
|
CN101262887A
(zh)
*
|
2005-07-15 |
2008-09-10 |
视可舒研究公司 |
糖尿病的眼科并发症的预防和治疗
|
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
|
EP1904056B1
(fr)
|
2005-07-18 |
2009-04-29 |
Minu, L.L.C. |
Utilisation d'un macrolide pour restaurer la sensation cornéenne
|
|
EP1912630A4
(fr)
*
|
2005-07-25 |
2012-10-03 |
Orthocon Inc |
Compositions et procedes destines a reduire les douleurs postoperatoires
|
|
US7785647B2
(en)
|
2005-07-25 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Methods of providing antioxidants to a drug containing product
|
|
US20100004156A1
(en)
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
|
US7735449B1
(en)
|
2005-07-28 |
2010-06-15 |
Advanced Cardiovascular Systems, Inc. |
Stent fixture having rounded support structures and method for use thereof
|
|
US7758778B2
(en)
*
|
2005-09-07 |
2010-07-20 |
Southwest Research Institute |
Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents
|
|
US9693967B2
(en)
*
|
2005-09-07 |
2017-07-04 |
Southwest Research Institute |
Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
|
|
US7261529B2
(en)
*
|
2005-09-07 |
2007-08-28 |
Southwest Research Institute |
Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
|
|
CA2602440A1
(fr)
*
|
2005-09-16 |
2007-04-05 |
Allergan, Inc. |
Compositions et methodes pour le transport intraoculaire d'agents therapeutiques
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
EP1940373B8
(fr)
*
|
2005-10-13 |
2015-06-24 |
Waratah Pharmaceuticals, Inc. |
1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer
|
|
CN101394834A
(zh)
|
2005-10-18 |
2009-03-25 |
阿勒根公司 |
用糖皮质激素衍生物选择性渗透后段组织来治疗眼睛
|
|
EP1956906A4
(fr)
|
2005-11-09 |
2009-12-30 |
Combinatorx Inc |
Procedes, compositions et kits pour le traitement de pathologies
|
|
CN101370505B
(zh)
|
2005-11-29 |
2012-03-21 |
史密丝克莱恩比彻姆公司 |
新生血管性眼病如黄斑变性、血管样纹、葡萄膜炎和黄斑水肿的治疗
|
|
US7976891B1
(en)
|
2005-12-16 |
2011-07-12 |
Advanced Cardiovascular Systems, Inc. |
Abluminal stent coating apparatus and method of using focused acoustic energy
|
|
US7591841B2
(en)
|
2005-12-16 |
2009-09-22 |
Advanced Cardiovascular Systems, Inc. |
Implantable devices for accelerated healing
|
|
CN101374946B
(zh)
|
2005-12-16 |
2017-07-18 |
伊西康公司 |
用于在组织相容性不匹配的移植中抑制有害的免疫反应的组合物和方法
|
|
JP5179376B2
(ja)
|
2005-12-19 |
2013-04-10 |
エシコン・インコーポレイテッド |
ローラーボトルでの分娩後取り出し細胞の体外増殖
|
|
US7867547B2
(en)
|
2005-12-19 |
2011-01-11 |
Advanced Cardiovascular Systems, Inc. |
Selectively coating luminal surfaces of stents
|
|
US7638156B1
(en)
|
2005-12-19 |
2009-12-29 |
Advanced Cardiovascular Systems, Inc. |
Apparatus and method for selectively coating a medical article
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
WO2007077551A2
(fr)
*
|
2005-12-30 |
2007-07-12 |
Mor Research Applications Ltd. |
Dispositif et procédé de traitement du sphincter anal
|
|
ES2653845T3
(es)
|
2006-01-17 |
2018-02-09 |
Novartis Ag |
Dispositivo de tratamiento de administración de fármaco
|
|
PT2526910E
(pt)
|
2006-01-17 |
2015-11-18 |
Transcend Medical Inc |
Dispositivo para tratamento de glaucoma
|
|
WO2008029276A2
(fr)
|
2006-02-02 |
2008-03-13 |
Allergan, Inc. |
Compositions et procédés de traitement d'une maladie ophtalmique
|
|
EP2001438A2
(fr)
|
2006-02-09 |
2008-12-17 |
Macusight, Inc. |
Formulations stables et leurs procedes de preparation et d'utilisation
|
|
EP1991210A1
(fr)
*
|
2006-02-15 |
2008-11-19 |
Intec Pharma Ltd. |
Système de gastro-rétention pour dé livrer des macromolécules
|
|
US20070197452A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Treatment of amyloid-related diseases
|
|
CA2642647A1
(fr)
*
|
2006-02-17 |
2007-11-15 |
Joanne Mclaurin |
Compositions et methodes destinees au traitement de troubles lies a l'agregation des proteines
|
|
US20070196428A1
(en)
|
2006-02-17 |
2007-08-23 |
Thierry Glauser |
Nitric oxide generating medical devices
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US7601383B2
(en)
|
2006-02-28 |
2009-10-13 |
Advanced Cardiovascular Systems, Inc. |
Coating construct containing poly (vinyl alcohol)
|
|
US7713637B2
(en)
|
2006-03-03 |
2010-05-11 |
Advanced Cardiovascular Systems, Inc. |
Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
|
|
BRPI0708725A2
(pt)
*
|
2006-03-09 |
2011-06-07 |
Waratah Pharmaceuticals Inc |
formulação de poliálcool de ciclohexano para o tratamento de doenças de agregação de proteìna
|
|
DK2001466T3
(en)
|
2006-03-23 |
2016-02-29 |
Santen Pharmaceutical Co Ltd |
LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
|
|
EP2004172B1
(fr)
*
|
2006-03-31 |
2019-03-13 |
Mati Therapeutics Inc. |
Structures d'administration de médicaments et compositions utilisées dans le système nasolacrymal
|
|
US7985441B1
(en)
|
2006-05-04 |
2011-07-26 |
Yiwen Tang |
Purification of polymers for coating applications
|
|
US8003156B2
(en)
|
2006-05-04 |
2011-08-23 |
Advanced Cardiovascular Systems, Inc. |
Rotatable support elements for stents
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US8304012B2
(en)
|
2006-05-04 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Method for drying a stent
|
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
CA2652449A1
(fr)
*
|
2006-05-19 |
2007-11-29 |
Waratah Pharmaceuticals Inc. |
Procedes de criblage pour modulateurs de beta-amyloide
|
|
US7775178B2
(en)
|
2006-05-26 |
2010-08-17 |
Advanced Cardiovascular Systems, Inc. |
Stent coating apparatus and method
|
|
US9561351B2
(en)
|
2006-05-31 |
2017-02-07 |
Advanced Cardiovascular Systems, Inc. |
Drug delivery spiral coil construct
|
|
US8568764B2
(en)
|
2006-05-31 |
2013-10-29 |
Advanced Cardiovascular Systems, Inc. |
Methods of forming coating layers for medical devices utilizing flash vaporization
|
|
US8703167B2
(en)
|
2006-06-05 |
2014-04-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
|
|
US8778376B2
(en)
|
2006-06-09 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
|
|
EP2383341A1
(fr)
|
2006-06-12 |
2011-11-02 |
Exegenics, Inc., D/b/a Opko Health, Inc. |
Compositions et procédés destinés à une inhibition de l'angiogenèse par les ARNsi
|
|
US8114150B2
(en)
|
2006-06-14 |
2012-02-14 |
Advanced Cardiovascular Systems, Inc. |
RGD peptide attached to bioabsorbable stents
|
|
US8603530B2
(en)
|
2006-06-14 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
Nanoshell therapy
|
|
US8048448B2
(en)
|
2006-06-15 |
2011-11-01 |
Abbott Cardiovascular Systems Inc. |
Nanoshells for drug delivery
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
ES2523640T3
(es)
|
2006-06-21 |
2014-11-28 |
Musc Foundation For Research Development |
Direccionamiento del factor H del complemento para el tratamiento de enfermedades
|
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US9028859B2
(en)
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
|
US8685430B1
(en)
|
2006-07-14 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Tailored aliphatic polyesters for stent coatings
|
|
US9039761B2
(en)
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
|
US8703169B1
(en)
|
2006-08-15 |
2014-04-22 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a coating comprising carrageenan and a biostable polymer
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
US20100173960A1
(en)
*
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
US8039010B2
(en)
*
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
CA2668954C
(fr)
|
2006-11-10 |
2020-09-08 |
Glaukos Corporation |
Derivation uveosclerale et procedes pour son implantation
|
|
US8143410B2
(en)
|
2006-11-16 |
2012-03-27 |
Allergan, Inc. |
Kinase inhibitors
|
|
EP2091566A4
(fr)
*
|
2006-11-24 |
2011-07-06 |
Waratah Pharmaceuticals Inc |
Traitements par combinaison pour la maladie d'alzheimer et des maladies analogues
|
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
CA2670990A1
(fr)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Procede pour determiner des emplacements oculaires optimaux pour des systemes d'administration de medicament
|
|
US8597673B2
(en)
|
2006-12-13 |
2013-12-03 |
Advanced Cardiovascular Systems, Inc. |
Coating of fast absorption or dissolution
|
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
WO2008097525A2
(fr)
|
2007-02-05 |
2008-08-14 |
Potentia Pharmaceuticals, Inc. |
Inhibition locale de complément destinée au traitement de troubles induits par le complément
|
|
BRPI0807571A2
(pt)
|
2007-02-22 |
2014-07-01 |
Othera Holding Inc |
Compostos de hidroxilamina e métodos de seu uso
|
|
CA2683548A1
(fr)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Utilisation de derives de cyclohexanehexol pour le traitement de maladies a repetition des polyglutamines
|
|
CA2683546A1
(fr)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Utilisation de derives de cyclohexanehexol dans le traitement de .alpha.-synucleinopathies
|
|
US20100168250A1
(en)
*
|
2007-04-12 |
2010-07-01 |
Antonio Cruz |
Use of cyclohexanehexol derivatives in the treatment of ocular disease
|
|
WO2008124931A1
(fr)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Utilisation de dérivés de cyclohexanehexol dans le traitement de la sclérose latérale amyotrophique
|
|
US8147769B1
(en)
|
2007-05-16 |
2012-04-03 |
Abbott Cardiovascular Systems Inc. |
Stent and delivery system with reduced chemical degradation
|
|
US9056155B1
(en)
|
2007-05-29 |
2015-06-16 |
Abbott Cardiovascular Systems Inc. |
Coatings having an elastic primer layer
|
|
US8048441B2
(en)
|
2007-06-25 |
2011-11-01 |
Abbott Cardiovascular Systems, Inc. |
Nanobead releasing medical devices
|
|
US8109904B1
(en)
|
2007-06-25 |
2012-02-07 |
Abbott Cardiovascular Systems Inc. |
Drug delivery medical devices
|
|
US9827210B2
(en)
*
|
2007-06-29 |
2017-11-28 |
Phovitreal Pty Ltd |
Treatment or prophylaxis of a neurological or neuropsychiatric disorders via ocular administration
|
|
EP2173289A4
(fr)
|
2007-07-17 |
2010-11-24 |
Transcend Medical Inc |
Implant oculaire avec de capacités d'expansion d'hydrogel
|
|
US20090104243A1
(en)
|
2007-09-07 |
2009-04-23 |
Qlt Plug Delivery, Inc. - Qpdi |
Drug cores for sustained release of therapeutic agents
|
|
WO2009032328A1
(fr)
|
2007-09-07 |
2009-03-12 |
Qlt Plug Delivery, Inc |
Implants lacrymaux et procédés associés
|
|
NZ583858A
(en)
|
2007-09-07 |
2012-08-31 |
Quadra Logic Tech Inc |
Lacrimal implant detection with detection device
|
|
WO2009046335A1
(fr)
|
2007-10-05 |
2009-04-09 |
Ethicon, Incorporated |
Réparation et régénération du tissu rénal au moyen de cellules provenant de tissus de cordon ombilical humain
|
|
CA3177952A1
(fr)
|
2007-10-12 |
2009-04-23 |
Astellas Institute For Regenerative Medicine |
Procedes ameliores pour la production de cellules rpe et de compositions de cellules rpe
|
|
CA2708364A1
(fr)
|
2007-12-11 |
2009-06-18 |
Efrat Ben-Zeev |
Composes a base de carboxamide et leur utilisation en tant qu'agonistes du recepteur des chimiokines
|
|
US8236538B2
(en)
|
2007-12-20 |
2012-08-07 |
Advanced Technologies And Regenerative Medicine, Llc |
Methods for sterilizing materials containing biologically active agents
|
|
EP2222281B1
(fr)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Procédé pour préparer des microparticules ayant un faible volume de solvant résiduel
|
|
RU2010136822A
(ru)
|
2008-02-18 |
2012-03-10 |
Клт Плаг Диливери, Инк. (Us) |
Лакримальные имплантаты и связанные с ними способы
|
|
CN104623741A
(zh)
|
2008-04-30 |
2015-05-20 |
马缇医疗股份有限公司 |
复合泪管植入物及相关方法
|
|
NZ588938A
(en)
|
2008-05-09 |
2013-03-28 |
Mati Therapeutics Inc |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
JP5591226B2
(ja)
|
2008-05-12 |
2014-09-17 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
眼内薬物送達装置および関連する方法
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
EP3298995A1
(fr)
|
2008-06-25 |
2018-03-28 |
Novartis AG |
Implant oculaire à capacités de changement de forme
|
|
US8796443B2
(en)
|
2008-09-22 |
2014-08-05 |
Rxi Pharmaceuticals Corporation |
Reduced size self-delivering RNAi compounds
|
|
CN101390825B
(zh)
*
|
2008-10-01 |
2010-12-29 |
山东省眼科研究所 |
一种伏立康唑眼内释药系统
|
|
JP2012505162A
(ja)
*
|
2008-10-09 |
2012-03-01 |
ワラタ ファーマシューティカルズ， インコーポレイテッド |
黄斑変性症関連障害を処置するためのｓｃｙｌｌｏ−イノシトールの使用
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
*
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
AU2009322279A1
(en)
|
2008-12-04 |
2011-07-14 |
Opko Pharmaceuticals, Llc |
Compositions and methods for selective inhibition of pro-angiogenic VEGF isoforms
|
|
US10179900B2
(en)
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
CA2747794C
(fr)
|
2008-12-19 |
2018-10-30 |
Advanced Technologies And Regenerative Medicine, Llc |
Traitement des poumons et des maladies et troubles pulmonaires
|
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
ES2920877T3
(es)
|
2009-01-28 |
2022-08-11 |
Alcon Inc |
Sistema de colocación de implantes oculares
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
WO2010090762A1
(fr)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Duplexes d'arn avec régions de nucléotide phosphorothioate à brin unique pour fonctionnalité supplémentaire
|
|
CA2750242C
(fr)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Delivrance de medicament par bouchons d'hydrogels
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
WO2010096822A2
(fr)
|
2009-02-23 |
2010-08-26 |
Qlt Plug Delivery, Inc. |
Implants lacrymaux et procédés associés
|
|
US20100226962A1
(en)
*
|
2009-03-03 |
2010-09-09 |
Rodstrom Theron R |
Peri-corneal drug delivery device
|
|
US8722034B2
(en)
|
2009-03-26 |
2014-05-13 |
Depuy Synthes Products Llc |
hUTC as therapy for Alzheimer's disease
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP4289416A3
(fr)
|
2009-05-18 |
2024-01-03 |
Dose Medical Corporation |
Implant oculaire à élution de médicament
|
|
IN2012DN00352A
(fr)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
EP2445481B1
(fr)
|
2009-06-18 |
2017-03-22 |
Rdd Pharma Ltd. |
Méthodes et dispositifs pour l'administration d'agents pharmaceutiques dans des orifices du corps
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
JP5886204B2
(ja)
*
|
2009-10-30 |
2016-03-16 |
アトーン ファルマ、インコーポレイテッドＡｔｏｎ Ｐｈａｒｍａ，Ｉｎｃ． |
眼内薬剤送達装置
|
|
US20110124736A1
(en)
|
2009-11-09 |
2011-05-26 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
|
CA2781149A1
(fr)
|
2009-11-17 |
2011-05-26 |
Advanced Cell Technology, Inc. |
Procedes de generation de cellules humaines de l'epithelium pigmentaire retinien (rpe) et preparations pharmaceutiques de celles-ci
|
|
RU2012127772A
(ru)
*
|
2009-12-04 |
2014-01-10 |
ОПКО ОФТЭЛМИКС, ЭлЭлСи |
Композиции и способы для ингибирования vegf
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
CN103200945B
(zh)
|
2010-03-24 |
2016-07-06 |
雷克西制药公司 |
眼部症候中的rna干扰
|
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
|
US9815890B2
(en)
|
2010-06-22 |
2017-11-14 |
The Regents Of The University Of Colorado, A Body Corporate |
Antibodies to the C3d fragment of complement component 3
|
|
WO2011163560A1
(fr)
|
2010-06-25 |
2011-12-29 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Méthodes de traitement utilisant l'acide sterculique
|
|
EP4524568A3
(fr)
|
2010-07-23 |
2025-06-18 |
Astellas Institute for Regenerative Medicine |
Procédés de détection de sous-populations rares de cellules et compositions de cellules hautement purifiées
|
|
HUE054113T2
(hu)
|
2010-08-05 |
2021-08-30 |
Forsight Vision4 Inc |
Injekciós készülék gyógyszerbejuttatáshoz
|
|
EP2600876B1
(fr)
|
2010-08-05 |
2015-04-29 |
Forsight Vision4, Inc. |
Procédés et appareils d'administration combinée de médicament
|
|
HRP20211909T1
(hr)
|
2010-08-05 |
2022-03-18 |
Forsight Vision4, Inc. |
Uređaj za liječenja oka
|
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
EP2654715B1
(fr)
|
2010-11-24 |
2017-01-25 |
Dose Medical Corporation |
Implant oculaire à élution de médicament
|
|
EP2691127B1
(fr)
*
|
2011-03-27 |
2021-01-13 |
Microsert Ltd |
Dispositifs miniaturisés implantés pour l'administration de médicaments, et systèmes porte-prothèse pour l'introduction de tels dispositifs
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
WO2012174064A1
(fr)
|
2011-06-14 |
2012-12-20 |
Bikam Pharmaceuticals, Inc. |
Ligands de liaison à une opsine, compositions et procédés d'utilisation
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
EP2739252A4
(fr)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
Administration de petites molécules à l'aide d'un dispositif thérapeutique implantable
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
ES2611807T3
(es)
|
2011-08-29 |
2017-05-10 |
Mati Therapeutics Inc. |
Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
|
|
EP4193907A1
(fr)
|
2011-09-13 |
2023-06-14 |
Glaukos Corporation |
Capteur physiologique intraoculaire
|
|
EP4643921A2
(fr)
|
2011-09-16 |
2025-11-05 |
ForSight Vision4, Inc. |
Appareil d'échange de fluide
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
EP2768307B1
(fr)
|
2011-10-19 |
2020-03-18 |
Bikam Pharmaceuticals, Inc. |
Ligands de liaison à une opsine, compositions et procédés d'utilisation
|
|
IL308205B2
(en)
|
2011-11-14 |
2025-10-01 |
Astellas Inst For Regenerative Medicine |
Pharmaceutical preparations of human RPE cells and their use
|
|
BR112014012997A2
(pt)
|
2011-11-30 |
2017-06-13 |
Bikam Pharmaceuticals Inc |
ligantes que se ligam à opsina, composições e métodos de uso
|
|
AU2012346537A1
(en)
|
2011-12-01 |
2014-07-17 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
CA2858161C
(fr)
|
2011-12-05 |
2020-03-10 |
Incept, Llc |
Procedes et compositions associes a un organogel medical
|
|
CN104837987B
(zh)
|
2011-12-23 |
2018-10-02 |
德普伊新特斯产品公司 |
人脐带组织来源的细胞的检测
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US10085633B2
(en)
|
2012-04-19 |
2018-10-02 |
Novartis Ag |
Direct visualization system for glaucoma treatment
|
|
BR102012009316A2
(pt)
*
|
2012-04-20 |
2013-11-26 |
Univ Minas Gerais |
Dispositivo de liberação prolongada de talidomida e uso em doenças oculares causadoras de neovascularização
|
|
US9241832B2
(en)
|
2012-04-24 |
2016-01-26 |
Transcend Medical, Inc. |
Delivery system for ocular implant
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
WO2013181498A1
(fr)
|
2012-06-01 |
2013-12-05 |
Surmodics, Inc. |
Appareil et méthode de revêtement de cathéters à ballonnet
|
|
EP3228286A1
(fr)
|
2012-09-17 |
2017-10-11 |
Novartis AG |
Dispositifs d'implant oculaire expansible
|
|
WO2014071044A1
(fr)
|
2012-11-01 |
2014-05-08 |
Allergan, Inc. |
Dérivés de 6,7-dialcoxy-3-isoquinoline substitués à titre d'inhibiteurs de phosphodiestérase 10 (pde10a)
|
|
US9763829B2
(en)
|
2012-11-14 |
2017-09-19 |
Novartis Ag |
Flow promoting ocular implant
|
|
ES2879430T3
(es)
|
2012-11-15 |
2021-11-22 |
Apellis Pharmaceuticals Inc |
Análogos de compstatina de acción prolongada y composiciones y métodos relacionados
|
|
RU2641021C2
(ru)
|
2013-02-15 |
2018-01-17 |
Аллерган, Инк. |
Имплантат для пролонгированной доставки лекарственного средства
|
|
CA2940513C
(fr)
|
2013-03-11 |
2023-08-15 |
University Of Florida Research Foundation, Inc. |
Delivrance d'une proteine a domaine de recrutement des caspases (card) en tant que therapie pour inflammation oculaire
|
|
MX363533B
(es)
|
2013-03-13 |
2019-03-27 |
Genzyme Corp |
Proteínas de fusión que comprenden partes de unión a pdgf y vegf y métodos de uso de las mismas.
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
EP2968113B8
(fr)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systèmes pour l'administration intra-oculaire entretenue de composés à faible solubilité provenant d'un implant de système de pose d'orifice
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US10308687B2
(en)
|
2013-03-15 |
2019-06-04 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
US9987163B2
(en)
|
2013-04-16 |
2018-06-05 |
Novartis Ag |
Device for dispensing intraocular substances
|
|
EP2991621B1
(fr)
|
2013-05-02 |
2020-12-09 |
Retina Foundation of the Southwest |
Implant oculaire à deux couches
|
|
EP2994758B1
(fr)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Marqueurs biologiques de la dégénérescence maculaire liée à l'âge (dmla)
|
|
US9333208B2
(en)
|
2013-07-16 |
2016-05-10 |
Movses H. Karakossian |
HCN inhibitors affecting ganglion cell function and visual function
|
|
US20150025061A1
(en)
|
2013-07-16 |
2015-01-22 |
Allergan, Inc. |
Gabaa receptor antagonists affecting ganglion cell function and visual acuity
|
|
WO2015168108A2
(fr)
|
2014-04-28 |
2015-11-05 |
Rxi Pharmaceuticals Corporation |
Procédés de traitement du cancer au moyen d'un acide nucléique deciblage de mdm2 ou mycn
|
|
JP2017514908A
(ja)
|
2014-05-01 |
2017-06-08 |
アールエックスアイ ファーマシューティカルズ コーポレーション |
核酸分子を利用する目の前部における障害の処置のための方法
|
|
EP3677229A1
(fr)
|
2014-05-29 |
2020-07-08 |
Glaukos Corporation |
Implants ayant des caractéristiques d'administration contrôlée de médicaments
|
|
US10562946B2
(en)
|
2014-06-20 |
2020-02-18 |
Genentech, Inc. |
Chagasin-based scaffold compositions, methods, and uses
|
|
EP3169289B1
(fr)
|
2014-07-15 |
2020-04-15 |
ForSight Vision4, Inc. |
Dispositif de pose d'implant oculaire
|
|
MX2017001818A
(es)
|
2014-08-08 |
2017-05-30 |
Forsight Vision4 Inc |
Formulaciones estables y solubles de inhibidores de receptor de quinasa tirosina y metodos de preparacion de los mismos.
|
|
KR102444092B1
(ko)
|
2014-08-19 |
2022-09-16 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
국소 약물 전달을 위한 임플란트 및 이의 사용 방법
|
|
US20180250224A1
(en)
*
|
2014-09-19 |
2018-09-06 |
Oxular Limited |
Ophthalmic Drug Compositions
|
|
MX383085B
(es)
|
2014-11-10 |
2025-03-13 |
Forsight Vision4 Inc |
Dispositivo de entrega de fármacos expandibles y método de uso.
|
|
CN105769430B
(zh)
*
|
2014-12-26 |
2018-09-28 |
易浦润（上海）生物技术有限公司 |
一种载药的泪小管栓子
|
|
WO2016115369A1
(fr)
|
2015-01-14 |
2016-07-21 |
Northwestern University |
Compositions, systèmes et procédés pour un dispositif ophtalmique spécifique à un patient
|
|
US9820954B2
(en)
|
2015-08-19 |
2017-11-21 |
Jenivision Inc. |
Quantitative peri-orbital application of ophthalmology drugs
|
|
WO2017040853A1
(fr)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Implants d'administration de médicament présentant capacité d'administration bidirectionnelle
|
|
WO2017053885A1
(fr)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Implants lacrymaux à caractéristiques d'administration de médicament régulée et leurs procédés d'utilisation
|
|
AU2016334247B2
(en)
|
2015-10-07 |
2021-09-30 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens
|
|
CA3005238A1
(fr)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Structures poreuses pour dispositifs d'administration de medicament a liberation prolongee
|
|
PT109154B
(pt)
*
|
2016-02-12 |
2019-11-05 |
Univ De Coimbra |
Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
|
|
US10883108B2
(en)
|
2016-03-31 |
2021-01-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
KR20180133440A
(ko)
|
2016-04-05 |
2018-12-14 |
포사이트 비젼4, 인크. |
이식 가능한 안구 약물 전달 장치
|
|
CN115120405A
(zh)
|
2016-04-20 |
2022-09-30 |
多斯医学公司 |
生物可吸收眼部药物的递送装置
|
|
US12226524B2
(en)
|
2016-05-02 |
2025-02-18 |
The Regents Of The University Of Michigan |
Coated implants for long-term controlled release of antibody therapeutics
|
|
CN109414460A
(zh)
|
2016-07-05 |
2019-03-01 |
詹森生物科技公司 |
使用祖细胞治疗视网膜血管病
|
|
WO2018093797A1
(fr)
|
2016-11-15 |
2018-05-24 |
The Schepens Eye Research Institute, Inc. |
Compositions et méthodes pour le traitement de l'angiogenèse aberrante
|
|
EP4585228A3
(fr)
|
2017-04-07 |
2025-10-15 |
Apellis Pharmaceuticals, Inc. |
Schémas posologiques et compositions et procédés associés
|
|
KR20240146696A
(ko)
|
2017-09-15 |
2024-10-08 |
옥슬러 리미티드 |
안과용 전달 장치
|
|
WO2019070917A1
(fr)
|
2017-10-03 |
2019-04-11 |
The Schepens Eye Research Institute, Inc. |
Composés et compositions pour inhiber la dégénérescence de l'épithélium pigmentaire rétinien et procédés les utilisant
|
|
US11739326B2
(en)
|
2017-11-14 |
2023-08-29 |
Massachusetts Eye And Ear Infirmary |
RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
|
AU2018372806B2
(en)
|
2017-11-21 |
2024-05-30 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
|
WO2019118938A1
(fr)
|
2017-12-15 |
2019-06-20 |
Apellis Pharmaceuticals, Inc. |
Schémas posologiques et compositions et procédés associés
|
|
WO2019173674A1
(fr)
|
2018-03-09 |
2019-09-12 |
Northwestern University |
Impression 3d à haut débit de lentilles d'imagerie asphérique personnalisées
|
|
MX2020011536A
(es)
|
2018-05-01 |
2020-11-24 |
Chibi Inc |
Deposito de liquido para liberacion sostenida no invasiva de agentes al ojo.
|
|
AU2019262061A1
(en)
*
|
2018-05-01 |
2020-11-26 |
Chibi, Inc. |
Eye drop formulation and method for sustained delivery of medicament to the retina
|
|
EP3801378A4
(fr)
|
2018-05-24 |
2022-02-23 |
Celanese EVA Performance Polymers LLC |
Dispositif implantable pour la libération prolongée d'un composé médicamenteux macromoléculaire
|
|
WO2019222856A1
(fr)
|
2018-05-24 |
2019-11-28 |
Nureva Inc. |
Procédé, appareil et supports lisibles par ordinateur pour gérer des sources sonores semi-constantes (persistantes) dans des zones de capture/foyer de microphones
|
|
WO2019226516A1
(fr)
|
2018-05-24 |
2019-11-28 |
Celanese EVA Performance Polymers Corporation |
Dispositif implantable pour la libération prolongée d'un composé médicamenteux macromoléculaire
|
|
US11628466B2
(en)
|
2018-11-29 |
2023-04-18 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
WO2021081117A2
(fr)
|
2019-10-24 |
2021-04-29 |
Labombard Denis E |
Dispositif oculaire et système d'administration de médicament, avec boîtier
|
|
US11173291B2
(en)
|
2020-03-20 |
2021-11-16 |
The Regents Of The University Of California |
Implantable drug delivery devices for localized drug delivery
|
|
US11344526B2
(en)
|
2020-03-20 |
2022-05-31 |
The Regents Of The University Of California |
Implantable drug delivery devices for localized drug delivery
|
|
US11338119B2
(en)
|
2020-03-20 |
2022-05-24 |
The Regents Of The University Of California |
Implantable drug delivery devices for localized drug delivery
|
|
WO2022231930A1
(fr)
|
2021-04-26 |
2022-11-03 |
Celanese Eva Performance Polymers Llc |
Dispositif implantable pour la libération prolongée d'un composé médicamenteux macromoléculaire
|
|
EP4444269A1
(fr)
|
2021-12-06 |
2024-10-16 |
Breye Therapeutics ApS |
Formulation de danegaptide pour application dans l'oeil
|
|
CN118946333A
(zh)
*
|
2022-01-24 |
2024-11-12 |
塞拉尼斯伊娃高性能聚合物公司 |
用于预防和/或治疗眼部病症的方法
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
WO2025015317A2
(fr)
|
2023-07-13 |
2025-01-16 |
Kriya Therapeutics, Inc. |
Fusions inhibitrices de la voie du complément et méthodes d'utilisation de celles-ci
|